# BELL therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bell-therapeutics

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.belltherapeutics.com
- Latest round: Seed (Sep 20, 2023)
- Investors on record: 3

## About

Founded in 2023 and based in Seoul, South Korea, BELL therapeutics  Inc. operates as a brain science-based digital therapy company that offers hearing rehabilitation digital therapy solutions for cochlear implant surgery patients. In September 2023, BELL therapeutics Inc. raised seed funding from FuturePlay, the Holistic Growth Initiative (HGI), and the Korea SMEs and Startups Agency. As of 2023, the company is led by its CEO, Jae-eun Lee.

BELL therapeutics develops and offers artificial intelligence-based digital therapeutics (DTx) for hearing loss patients. The company provides a WowLog system, which is a Cochlear Log system that helps hearing-impaired people improve their hearing skills. The company develops new treatments for hearing loss, such as therapies that use music to stimulate the auditory system.

## Funding rounds

- Seed, Sep 20, 2023 — Korea SMEs and Startups Agency, FuturePlay, Holistic Growth Initiative

## Investors

- Korea SMEs and Startups Agency — Seed
- FuturePlay (https://capitalatlas.ai/funds/futureplay) — Seed
- Holistic Growth Initiative (https://capitalatlas.ai/funds/holistic-growth-initiative) — Seed